The protective effect of herniarin on genotoxicity and apoptosis induced by cisplatin in bone marrow cells of rats

References

• Ahmad, A. and Misra, L., 1997. Isolation of herniarin and other constituents from Matricaria chamomilla flowers. International Journal of Pharmacognosy, 35 (2), 121–125.
   Web of Science ®Google Scholar
• Attia, S.M., 2010. The impact of quercetin on cisplatin-induced clastogenesis and apoptosis in murine marrow cells. Mutagenesis, 25 (3), 281–288.
   PubMed Web of Science ®Google Scholar
• Attia, S.M., 2012. Influence of resveratrol on oxidative damage in genomic DNA and apoptosis induced by cisplatin. Mutation Research, 741 (1–2), 22–31.
   PubMed Web of Science ®Google Scholar
• Barzilai, A. and Yamamoto, K.-I., 2004. DNA damage responses to oxidative stress. DNA Repair, 3 (8–9), 1109–1115.
   PubMed Web of Science ®Google Scholar
• Brown, S.A., 1963. Biosynthesis of the coumarins IV. The formation of coumarin and herniarin in lavender. Phytochemistry, 2 (2), 137–144.
   Web of Science ®Google Scholar
• Cheki, M., et al., 2019a. Metformin attenuates cisplatin-induced genotoxicity and apoptosis in rat bone marrow cells. Drug and Chemical Toxicology, 1–8. doi:https://doi.org/10.1080/01480545.2019.1609024
   Web of Science ®Google Scholar
• Cheki, M., et al., 2019b. Glucosamine protects rat bone marrow cells against cisplatin-induced genotoxicity and cytotoxicity. Anti-Cancer Agents in Medicinal Chemistry, 19 (14), 1695–1702.
   PubMed Web of Science ®Google Scholar
• Conklin, K.A., 2004. Cancer chemotherapy and antioxidants. The Journal of Nutrition, 134 (11), 3201S–3204S.
   PubMed Web of Science ®Google Scholar
• Dizdaroglu, M., et al., 2002. Free radical-induced damage to DNA: mechanisms and measurement. Free Radical Biology & Medicine, 32 (11), 1102–1115.
   PubMed Web of Science ®Google Scholar
• dos Santos, G.C., et al., 2012. Protective effect of bixin on cisplatin-induced genotoxicity in PC12 cells. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association, 50 (2), 335–340.
   PubMed Web of Science ®Google Scholar
• Elsendoorn, T., et al., 2001. Chemotherapy-induced chromosomal damage in peripheral blood lymphocytes of cancer patients supplemented with antioxidants or placebo. Mutation Research, 498 (1–2), 145–158.
   PubMed Web of Science ®Google Scholar
• Evangelista, C.M.W., et al., 2004. Effects of the olive, extra virgin olive and canola oils on cisplatin-induced clastogenesis in Wistar rats. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association, 42 (8), 1291–1297.
   PubMed Web of Science ®Google Scholar
• Finn, G., Creaven, B., and Egan, D., 2001. Study of the in vitro cytotoxic potential of natural and synthetic coumarin derivatives using human normal and neoplastic skin cell lines. Melanoma Research, 11 (5), 461–467.
   PubMed Web of Science ®Google Scholar
• Fram, R.J., 1992. Cisplatin and platinum analogues: recent advances. Current Opinion in Oncology, 4 (6), 1073–1079.
   PubMedGoogle Scholar
• Haghighitalab, A., et al., 2014. Enhancement of cisplatin cytotoxicity in combination with herniarin in vitro. Drug and Chemical Toxicology, 37 (2), 156–162.
   PubMed Web of Science ®Google Scholar
• Halliwell, B. and Whiteman, M., 2004. Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? British Journal of Pharmacology, 142 (2), 231–255.
   PubMed Web of Science ®Google Scholar
• Hamilton, M.L., et al., 2001. Does oxidative damage to DNA increase with age? Proceedings of the National Academy of Sciences of the United States of America, 98 (18), 10469–10474.
   PubMed Web of Science ®Google Scholar
• Kartalou, M. and Essigmann, J.M., 2001. Recognition of cisplatin adducts by cellular proteins. Mutation Research, 478 (1–2), 1–21.
   PubMed Web of Science ®Google Scholar
• Khandelwal, N. and Abraham, S.K., 2014. Protective effects of common anthocyanidins against genotoxic damage induced by chemotherapeutic drugs in mice. Planta Medica, 80 (15), 1278–1283.
   PubMed Web of Science ®Google Scholar
• Lamson, D.W. and Brignall, M.S., 2000. Antioxidants and cancer, part 3: quercetin. Alternative Medicine Review: a Journal of Clinical Therapeutic, 5 (3), 196–208.
   PubMedGoogle Scholar
• Loehrer, P.J. and Einhorn, L.H., 1984. Drugs five years later. Cisplatin. Annals of Internal Medicine, 100 (5), 704–713.
   PubMed Web of Science ®Google Scholar
• Ma, C.M., Winsor, L., and Daneshtalab, M., 2007. Quantification of spiroether isomers and herniarin of different parts of Matricaria matricarioides and flowers of Chamaemelum nobile. Phytochemical Analysis, 18 (1), 42–49.
   PubMed Web of Science ®Google Scholar
• Marshall, M., et al., 1994. Growth-inhibitory effects of coumarin (1, 2-benzopyrone) and 7-hydroxycoumarin on human malignant cell lines in vitro. Journal of Cancer Research and Clinical Oncology, 120 (S1), S3–S10.
   PubMed Web of Science ®Google Scholar
• Miller, R., et al., 2010. Mechanisms of cisplatin nephrotoxicity. Toxins, 2 (11), 2490–2518.
   PubMed Web of Science ®Google Scholar
• Misra, S. and Choudhury, R.C., 2006. Vitamin C modulation of cisplatin-induced cytogenotoxicity in bone marrow, spermatogonia and its transmission in the male germline of Swiss mice. Journal of Chemotherapy, 18 (2), 182–187.
   PubMed Web of Science ®Google Scholar
• Molnar, M., et al., 2017. Comparison of various techniques for the extraction of umbelliferone and herniarin in Matricaria chamomilla processing fractions. Chemistry Central Journal, 11 (1), 78.
   PubMedGoogle Scholar
• Osanto, S., et al., 1991. Increased frequency of chromosomal damage in peripheral blood lymphocytes up to nine years following curative chemotherapy of patients with testicular carcinoma. Environmental and Molecular Mutagenesis, 17 (2), 71–78.
   PubMed Web of Science ®Google Scholar
• Pabla, N., and Dong, Z., 2008. Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney International, 73 (9), 994–1007.
   PubMed Web of Science ®Google Scholar
• Ramazan Yılmaz, H., et al., 2010. Anticlastogenic effect of caffeic acid phenethyl ester on cisplatin-induced chromosome aberrations in rat bone marrow cells. Toxicology and Industrial Health, 26 (1), 33–37.
   PubMed Web of Science ®Google Scholar
• Rezaee, R., et al., 2014. Antigenotoxic activities of the natural dietary coumarins umbelliferone, herniarin and 7-isopentenyloxy coumarin on human lymphocytes exposed to oxidative stress. Drug and Chemical Toxicology, 37 (2), 144–148.
   PubMed Web of Science ®Google Scholar
• Rjiba-Touati, K., et al., 2012. Induction of DNA fragmentation, chromosome aberrations and micronuclei by cisplatin in rat bone-marrow cells: protective effect of recombinant human erythropoietin. Mutation Research, 747 (2), 202–206.
   PubMed Web of Science ®Google Scholar
• Schmid, W., 1976. The micronucleus test for cytogenetic analysis. In: A. Hollaender, ed. Chemical mutagens. New York, NY: Springer, 31–53.
   Google Scholar
• Serpeloni, J.M., et al., 2010. Lutein improves antioxidant defense in vivo and protects against DNA damage and chromosome instability induced by cisplatin. Archives of Toxicology, 84 (10), 811–822.
   PubMed Web of Science ®Google Scholar
• Weijl, N., et al., 2004. Supplementation with antioxidant micronutrients and chemotherapy-induced toxicity in cancer patients treated with cisplatin-based chemotherapy: a randomised, double-blind, placebo-controlled study. European Journal of Cancer, 40 (11), 1713–1723.
   PubMed Web of Science ®Google Scholar